Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The high mobility group box 1 pseudogene family consists of non-functional genomic copies of the HMGB1 gene. These pseudogenes are transcriptionally inactive or only expressed at low levels, and there is no evidence that they encode a functional protein. Some HMGB1 pseudogenes might influence the expression of the parental HMGB1 gene through RNA-mediated mechanisms, such as acting as competitive endogenous RNAs. The entry "HMGB1P32" appears unrecognized; HMGB1P1 is the canonical pseudogene described in literature and databases. There is no evidence that any HMGB1 pseudogene functions as a receptor, enzyme, transporter, or therapeutic target.
Not applicable; pseudogenes do not encode functional protein and are not direct drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 1 (HMGB1P1).